Αποτελέσματα Αναζήτησης
4 Ιαν 2023 · [On December 22, 2022], the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety ...
6 Μαρ 2024 · Treatment-related adverse events were more common in the islatravir plus lenacapavir group (17.3% vs 5.8%), but all were mild to moderate. The most common side effects in this group were dry mouth and nausea. Two people discontinued the drugs due to adverse events unrelated to treatment.
21 Ιουν 2023 · Data to inform the switch from a ritonavir-boosted protease inhibitor (PI) to dolutegravir in patients living with human immunodeficiency virus (HIV) infection who do not have genotype...
24 Ιουλ 2024 · A twice-yearly PrEP choice could overcome challenges with respect to adherence and persistence and result in substantial protection against HIV infection for women worldwide.
3 Οκτ 2024 · A new drug to prevent HIV infection is showing hugely promising results in clinical trials when injected every six months.
31 Ιουλ 2024 · The following table lists HIV medicines recommended for the treatment of HIV infection in the United States, based on the U.S. Department of Health and Human Services (HHS) HIV and AIDS medical practice guidelines. All of these drugs are approved by the U.S. Food and Drug Administration (FDA).
24 Ιουλ 2024 · CNN —. Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa.
